Boehringer Ingelheim (Denmark)

Boehringer Ingelheim (Denmark)

C.H. Boehringer Sohn AG & Co. KG is the parent company of the Boehringer Ingelheim group, which was founded in 1885 by Albert Boehringer in Ingelheim am Rhein, Germany. As of 2018, Boehringer Ingelheim is one of the world's largest pharmaceutical companies, and the largest private one. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Boehringer Ingelheim (Denmark), Denmark, covering academic research published from 2002 to 2024. Read More.


Open Access Percentage

68%


Total
Publications

95


Total Open
Publications

65


Total
Citations

3K


Open Access
Percentage

68%


Total
Publications

95


Total Open
Publications

65


Total
Citations

3K

Wikipedia

Website

download

Breakdown

44% 24% 1% 31%

Publisher Open

44%

Both

24%

Other Platform Open

1%

Closed

31%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

024681012141618Total Publications
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

24%OA Journal

OA Journal 24%

16

Hybrid 55%

36

No Guarantees 21%

14

Other Platform Open

Institution 79%

19

Domain 71%

17

Other Internet 13%

3

Preprint 0%

0

Public 0%

0

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
17
Elsevier - Scopus
Institution
9
RISalud Institutional Health Repository of AndalucĂ­a
Institution
4
Unknown Repository
Other Internet
2
Europe PMC
Domain
2
Digital Access to Libraries
Institution
2
ZB MED - Informationszentrum Lebenswissenschaften
Institution
1
University of Oslo - Duo Research Archive
Institution
1
Universita Degli Studi Di Milano - Archivio Istituzionale della Ricerca
Institution
1
Saxon State and University Library Dresden - Qucosa
Institution
1
1 / 2

Data updated 18 August 2025

Share

Share

Share